217 related articles for article (PubMed ID: 32165410)
21. Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis.
Qi X; Lewin AS; Sun L; Hauswirth WW; Guy J
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):681-91. PubMed ID: 17251466
[TBL] [Abstract][Full Text] [Related]
22. Spermidine alleviates severity of murine experimental autoimmune encephalomyelitis.
Guo X; Harada C; Namekata K; Kimura A; Mitamura Y; Yoshida H; Matsumoto Y; Harada T
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2696-703. PubMed ID: 21228387
[TBL] [Abstract][Full Text] [Related]
23. Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis.
Guo X; Namekata K; Kimura A; Noro T; Azuchi Y; Semba K; Harada C; Yoshida H; Mitamura Y; Harada T
Neurosci Lett; 2015 Apr; 592():27-31. PubMed ID: 25736951
[TBL] [Abstract][Full Text] [Related]
24. Neuronal NMNAT2 Overexpression Does Not Achieve Significant Neuroprotection in Experimental Autoimmune Encephalomyelitis/Optic Neuritis.
Liu P; Huang H; Fang F; Liu L; Li L; Feng X; Chen W; Dalal R; Sun Y; Hu Y
Front Cell Neurosci; 2021; 15():754651. PubMed ID: 34707482
[TBL] [Abstract][Full Text] [Related]
25. Deletion of Arginase 2 Ameliorates Retinal Neurodegeneration in a Mouse Model of Multiple Sclerosis.
Palani CD; Fouda AY; Liu F; Xu Z; Mohamed E; Giri S; Smith SB; Caldwell RB; Narayanan SP
Mol Neurobiol; 2019 Dec; 56(12):8589-8602. PubMed ID: 31280447
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory demyelination induces glia alterations and ganglion cell loss in the retina of an experimental autoimmune encephalomyelitis model.
Horstmann L; Schmid H; Heinen AP; Kurschus FC; Dick HB; Joachim SC
J Neuroinflammation; 2013 Oct; 10():120. PubMed ID: 24090415
[TBL] [Abstract][Full Text] [Related]
27. Pterostilbene Protects the Optic Nerves and Retina in a Murine Model of Experimental Autoimmune Encephalomyelitis via Activation of SIRT1 Signaling.
Guo J; Wang J; Guo R; Shao H; Guo L
Neuroscience; 2022 Apr; 487():35-46. PubMed ID: 35090883
[TBL] [Abstract][Full Text] [Related]
28. Acriflavine, a HIF-1 inhibitor, preserves vision in an experimental autoimmune encephalomyelitis model of optic neuritis.
Anders JJ; Elwood BW; Kardon RH; Gramlich OW
Front Immunol; 2023; 14():1271118. PubMed ID: 37942317
[TBL] [Abstract][Full Text] [Related]
29. Targeting Cholesterol Homeostasis Improves Recovery in Experimental Optic Neuritis.
Godwin CR; Anders JJ; Cheng L; Elwood BW; Kardon RH; Gramlich OW
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291646
[TBL] [Abstract][Full Text] [Related]
30. Protective effect and mechanism of nicotinamide adenine dinucleotide against optic neuritis in mice with experimental autoimmune encephalomyelitis.
Guo J; Li B; Wang J; Guo R; Tian Y; Song S; Guo L
Int Immunopharmacol; 2021 Sep; 98():107846. PubMed ID: 34174704
[TBL] [Abstract][Full Text] [Related]
31. Limiting Neuronal Nogo Receptor 1 Signaling during Experimental Autoimmune Encephalomyelitis Preserves Axonal Transport and Abrogates Inflammatory Demyelination.
Lee JY; Kim MJ; Thomas S; Oorschot V; Ramm G; Aui PM; Sekine Y; Deliyanti D; Wilkinson-Berka J; Niego B; Harvey AR; Theotokis P; McLean C; Strittmatter SM; Petratos S
J Neurosci; 2019 Jul; 39(28):5562-5580. PubMed ID: 31061088
[TBL] [Abstract][Full Text] [Related]
32. Amnion-Derived Multipotent Progenitor Cells Suppress Experimental Optic Neuritis and Myelitis.
Khan RS; Ross AG; Willett K; Dine K; Banas R; Brown LR; Shindler KS
Neurotherapeutics; 2021 Jan; 18(1):448-459. PubMed ID: 33067748
[TBL] [Abstract][Full Text] [Related]
33. Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis.
Quinn TA; Dutt M; Shindler KS
Front Neurol; 2011; 2():50. PubMed ID: 21852980
[TBL] [Abstract][Full Text] [Related]
34. Retinal ganglion cell damage induced by spontaneous autoimmune optic neuritis in MOG-specific TCR transgenic mice.
Guan Y; Shindler KS; Tabuena P; Rostami AM
J Neuroimmunol; 2006 Sep; 178(1-2):40-8. PubMed ID: 16828169
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotection by eIF2α-CHOP inhibition and XBP-1 activation in EAE/optic neuritiss.
Huang H; Miao L; Liang F; Liu X; Xu L; Teng X; Wang Q; Ridder WH; Shindler KS; Sun Y; Hu Y
Cell Death Dis; 2017 Jul; 8(7):e2936. PubMed ID: 28726788
[TBL] [Abstract][Full Text] [Related]
36. Early alpha-lipoic acid therapy protects from degeneration of the inner retinal layers and vision loss in an experimental autoimmune encephalomyelitis-optic neuritis model.
Dietrich M; Helling N; Hilla A; Heskamp A; Issberner A; Hildebrandt T; Kohne Z; Küry P; Berndt C; Aktas O; Fischer D; Hartung HP; Albrecht P
J Neuroinflammation; 2018 Mar; 15(1):71. PubMed ID: 29514678
[TBL] [Abstract][Full Text] [Related]
37. Timing of corticosteroid therapy is critical to prevent retinal ganglion cell loss in experimental optic neuritis.
Dutt M; Tabuena P; Ventura E; Rostami A; Shindler KS
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1439-45. PubMed ID: 19892867
[TBL] [Abstract][Full Text] [Related]
38. Treatment with MDL 72527 Ameliorated Clinical Symptoms, Retinal Ganglion Cell Loss, Optic Nerve Inflammation, and Improved Visual Acuity in an Experimental Model of Multiple Sclerosis.
Liu F; Alfarhan M; Baker L; Shenoy N; Liao Y; Henry-Ojo HO; Somanath PR; Narayanan SP
Cells; 2022 Dec; 11(24):. PubMed ID: 36552864
[TBL] [Abstract][Full Text] [Related]
39. Retinal ganglion cell loss induced by acute optic neuritis in a relapsing model of multiple sclerosis.
Shindler KS; Guan Y; Ventura E; Bennett J; Rostami A
Mult Scler; 2006 Oct; 12(5):526-32. PubMed ID: 17086896
[TBL] [Abstract][Full Text] [Related]
40. Gene therapy with mitochondrial heat shock protein 70 suppresses visual loss and optic atrophy in experimental autoimmune encephalomyelitis.
Talla V; Porciatti V; Chiodo V; Boye SL; Hauswirth WW; Guy J
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5214-26. PubMed ID: 25015358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
